These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9150391

  • 1. Inactivation of p53 results in high rates of homologous recombination.
    Mekeel KL, Tang W, Kachnic LA, Luo CM, DeFrank JS, Powell SN.
    Oncogene; 1997 Apr 17; 14(15):1847-57. PubMed ID: 9150391
    [Abstract] [Full Text] [Related]

  • 2. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines.
    Slebos RJ, Taylor JA.
    Biochem Biophys Res Commun; 2001 Feb 16; 281(1):212-9. PubMed ID: 11178982
    [Abstract] [Full Text] [Related]

  • 3. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control.
    Willers H, McCarthy EE, Wu B, Wunsch H, Tang W, Taghian DG, Xia F, Powell SN.
    Oncogene; 2000 Feb 03; 19(5):632-9. PubMed ID: 10698508
    [Abstract] [Full Text] [Related]

  • 4. Targeted inactivation of p53 in human cells does not result in aneuploidy.
    Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B, Lengauer C.
    Cancer Res; 2002 Feb 15; 62(4):1129-33. PubMed ID: 11861393
    [Abstract] [Full Text] [Related]

  • 5. The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses.
    Kohli M, Jorgensen TJ.
    Biochem Biophys Res Commun; 1999 Apr 02; 257(1):168-76. PubMed ID: 10092528
    [Abstract] [Full Text] [Related]

  • 6. Involvement of human p53 in induced intrachromosomal recombination in Saccharomyces cerevisiae.
    Del Carratore R, Petrucci A, Simili M, Fronza G, Galli A.
    Mutagenesis; 2004 Sep 02; 19(5):333-9. PubMed ID: 15388804
    [Abstract] [Full Text] [Related]

  • 7. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein.
    Bertrand P, Rouillard D, Boulet A, Levalois C, Soussi T, Lopez BS.
    Oncogene; 1997 Mar 06; 14(9):1117-22. PubMed ID: 9070661
    [Abstract] [Full Text] [Related]

  • 8. An unexpected role for p53 in augmenting SV40 large T antigen-mediated tumorigenesis.
    Herzig M, Novatchkova M, Christofori G.
    Biol Chem; 1999 Feb 06; 380(2):203-11. PubMed ID: 10195427
    [Abstract] [Full Text] [Related]

  • 9. Hypoxia-induced apoptosis in human cells with normal p53 status and function, without any alteration in the nuclear protein level.
    Amellem O, Stokke T, Sandvik JA, Smedshammer L, Pettersen EO.
    Exp Cell Res; 1997 May 01; 232(2):361-70. PubMed ID: 9168813
    [Abstract] [Full Text] [Related]

  • 10. p53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts.
    Cistulli CA, Kaufmann WK.
    Cancer Res; 1998 May 01; 58(9):1993-2002. PubMed ID: 9581844
    [Abstract] [Full Text] [Related]

  • 11. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL.
    Oncogene; 2001 Jul 27; 20(33):4441-9. PubMed ID: 11494139
    [Abstract] [Full Text] [Related]

  • 12. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
    Li PX, Ngo D, Brade AM, Klamut HJ.
    Cancer Gene Ther; 1999 Jul 27; 6(2):179-90. PubMed ID: 10195885
    [Abstract] [Full Text] [Related]

  • 13. p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination.
    Linke SP, Sengupta S, Khabie N, Jeffries BA, Buchhop S, Miska S, Henning W, Pedeux R, Wang XW, Hofseth LJ, Yang Q, Garfield SH, Stürzbecher HW, Harris CC.
    Cancer Res; 2003 May 15; 63(10):2596-605. PubMed ID: 12750285
    [Abstract] [Full Text] [Related]

  • 14. The impact of p53 status on cellular sensitivity to antifolate drugs.
    Lu X, Errington J, Curtin NJ, Lunec J, Newell DR.
    Clin Cancer Res; 2001 Jul 15; 7(7):2114-23. PubMed ID: 11448931
    [Abstract] [Full Text] [Related]

  • 15. The interaction of p53 with replication protein A mediates suppression of homologous recombination.
    Romanova LY, Willers H, Blagosklonny MV, Powell SN.
    Oncogene; 2004 Dec 02; 23(56):9025-33. PubMed ID: 15489903
    [Abstract] [Full Text] [Related]

  • 16. Wild-type p53 inhibits replication-associated homologous recombination.
    Janz C, Wiesmüller L.
    Oncogene; 2002 Aug 29; 21(38):5929-33. PubMed ID: 12185593
    [Abstract] [Full Text] [Related]

  • 17. Increased ultraviolet sensitivity and chromosomal instability related to P53 function in the xeroderma pigmentosum variant.
    Cleaver JE, Afzal V, Feeney L, McDowell M, Sadinski W, Volpe JP, Busch DB, Coleman DM, Ziffer DW, Yu Y, Nagasawa H, Little JB.
    Cancer Res; 1999 Mar 01; 59(5):1102-8. PubMed ID: 10070969
    [Abstract] [Full Text] [Related]

  • 18. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
    Slebos RJ, Kessis TD, Chen AW, Han SM, Hedrick L, Cho KR.
    Virology; 1995 Apr 01; 208(1):111-20. PubMed ID: 11831691
    [Abstract] [Full Text] [Related]

  • 19. Restoration of p53 function in anaplastic Wilms' tumor.
    Delatte SJ, Hazen-Martin DJ, Re GG, Kelly JR, Sutphin A, Tagge EP.
    J Pediatr Surg; 2001 Jan 01; 36(1):43-50. PubMed ID: 11150436
    [Abstract] [Full Text] [Related]

  • 20. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
    Srivenugopal KS, Shou J, Mullapudi SR, Lang FF, Rao JS, Ali-Osman F.
    Clin Cancer Res; 2001 May 01; 7(5):1398-409. PubMed ID: 11350911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.